5 HTP causes weight loss

5-HTP from Griffonia: herbal mood enhancer

 

Birdsall, T. (1998): 5-Hydroxytryptophan: A Clinically-Effective Serotonin Precursor. Alternative Medicine Review 1998: 3: 271-80. http://www.altmedrev.com/archive/publications/3/4/271.pdf, accessed on July 1, 2019.

De Benedittis, G. & Massei, R. (1985): Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo. J Neurosurg Sci 1985 Jul-Sep: 29: 239-48. https://www.ncbi.nlm.nih.gov/pubmed/3913752, accessed on July 3, 2019.

Emanuele, E. et al. (2010): An open-label trial of L-5-hydroxytryptophan in subjects with romantic stress. Neuro Endocrinol Lett 2010: 31: 663-6. https://www.ncbi.nlm.nih.gov/pubmed/21178946, accessed on July 2nd, 2019.

Francescangeli, J. et al. (2019): The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice. Int J Mol Sci 2019 May: 20. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539562/, accessed on July 1, 2019.

Ghia, J. et al. (2009): Serotonin Has a Key Role in Pathogenesis of Experimental Colitis. Gastroenterology 2009: 137: 1649-60. https://pdfs.semanticscholar.org/4d8c/4255dec9d940396308706706e5c55f679042.pdf, accessed on July 1, 2019.

Halford J. et al. (2007): Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs. 2007: 67: 27-55. https://www.ncbi.nlm.nih.gov/pubmed/17209663, accessed on July 2nd, 2019.

Halford J. et al. (2012): 5-HT (2C) receptor agonists and the control of appetite. Handb Exp Pharmacol 2012: 209: 349-56. https://www.ncbi.nlm.nih.gov/pubmed/22249823, accessed on July 2nd, 2019.

Hinz, M. et al. (2012): 5-HTP efficacy and contraindications. Neuropsychiatr Dis Treat 2012 Jul: 8: 323-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415362/, accessed on July 1, 2019.

Juhl, J. (1998): Fibromyalgia and the Serotonin Pathway. Alternative Medicine Review 1998: 3: 367-75. http://archive.foundationalmedicinereview.com/publications/3/5/367.pdf, accessed on July 1, 2019.

Kahn RS, Westenberg HG et al. (1987): Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol. 1987 Jan. https://www.ncbi.nlm.nih.gov/pubmed/3312397, accessed on: 01.08.2019.

Kahn, R. et al. (1987): Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol 1987 Jan: 2: 33-45. https://www.ncbi.nlm.nih.gov/pubmed/3312397, accessed on July 2nd, 2019.

Kushwaha, S. et al. (2014): Serotonin syndrome following levodopa treatment in diffuse Lewy body disease. BMJ Case Rep 2014 Sep. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173194/, accessed on July 1, 2019.

Lemaire, P. & Adosraku, R. (2002): An HPLC method for the direct assay of the serotonin precursor, 5-hydroxytrophan, in seeds of Griffonia simplicifolia. Phytochem Anal 2002 Nov-Dec: 13: 333-7. https://www.ncbi.nlm.nih.gov/pubmed/12494751, accessed on July 1, 2019.

Maron, E. et al. (2004): The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol 2004 Jun: 18: 194-9. https://www.ncbi.nlm.nih.gov/pubmed/15260907, accessed on July 2nd, 2019.

Marty Hinz, Alvin Stein et al. (2012): 5-HTP efficacy and contraindications. Neuropsychiatric Dis Treat. 2012.https: //www.ncbi.nlm.nih.gov/pmc/articles/PMC3415362/, accessed on: August 1, 2019.

Meyers, S. (2000): Use of Neurotransmitter Precursors for Treatment of Depression. Altern Med Rev 2000: 5: 64-71. http://archive.foundationalmedicinereview.com/publications/5/1/64.pdf, accessed on July 2nd, 2019.

Morrow, J. et al. (2008): Effects of Serotonergic Activation by 5-Hydroxytryptophan on Sleep and Body Temperature of C57BL / 6J and Interleukin-6-Deficient Mice are Dose and Time Related. Sleep 2008 Jan: 31: 21-33. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225553/, accessed on July 2nd, 2019.

Nicolodi, M. & Sicuteri, F. (1996): Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Adv Exp Med Biol. 1996: 398: 378-9. https://www.ncbi.nlm.nih.gov/pubmed/8906292, accessed on July 3, 2019.

NN (1998): Monograph - 5-Hydroxytryptophan. Alternative Medicine Review 1998: 3: 224- 6. http://www.altmedrev.com/archive/publications/3/3/224.pdf, accessed on July 2, 2019.

Patel, K. (2019): 5-HTP. Online portal. https://examine.com/supplements/5-htp/#safety-and-toxicity_clinically-relevant, accessed on July 1, 2019.

Ribeiro, C. (2000): L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society. Headache 2000 Jun: 40: 451-6. https://www.ncbi.nlm.nih.gov/pubmed/10849040, accessed on July 3, 2019.

Rondanelli, M. et al. (2009): Satiety and amino-acid profile in overweight women after a new treatment using a natural plant extract sublingual spray formulation. Int J Obes (Lond) 2009 Oct: 33: 1174-82. https://www.ncbi.nlm.nih.gov/pubmed/19752879, accessed on July 2nd, 2019.

Rondanelli, M. et al. (2012): Relationship between the absorption of 5-hydroxytryptophan from an integrated diet, by means of Griffonia simplicifolia extract, and the effect on satiety in overweight females after oral spray administration. Eat Weight Disord 2012 Mar: 17: e22-8. https://www.ncbi.nlm.nih.gov/pubmed/22142813, accessed on July 2nd, 2019.

Sallée, M. et al. (2014): The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease. Toxins (Basel) 2014 Mar: 6: 934-49. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968369/, accessed on July 1, 2019.

Sarzi Puttini, P. & Caruso, I. (1992): Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res 1992 Apr: 20: 182-9. https://www.ncbi.nlm.nih.gov/pubmed/1521674, accessed on July 3, 2019.

Schefold, J. et al. (2009): Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant 2009 Jun: 24: 1901-8. https://www.ncbi.nlm.nih.gov/pubmed/19155537, accessed on July 1, 2019.

Schruers, K. et al. (2002): Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients. Psychiatry Res 2002 Dec: 113: 237-43. https://www.ncbi.nlm.nih.gov/pubmed/12559480, accessed on July 2nd, 2019.

Shaw, K. et al. (2002): Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev 2002: 1. https://www.ncbi.nlm.nih.gov/pubmed/11869656, accessed on July 2nd, 2019.

Shell, W. et al. (2010): A randomized, placebo-controlled trial of an amino acid preparation on timing and quality of sleep. On J Ther 2010 Mar-Apr: 17: 133-9. https://www.ncbi.nlm.nih.gov/pubmed/19417589, accessed on July 2nd, 2019.

Sternberg, E. et al. (1980): Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med 1980 Oct: 303: 782-7. https://www.ncbi.nlm.nih.gov/pubmed/6997735, accessed on July 1, 2019.

Turner, E. et al. (2006): Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics 2006 Mar: 109: 325-38. https://escholarship.org/uc/item/58h866d5, accessed on July 1, 2019.

Vigliante, I. et al. (2019): Chemical Characterization and DNA Fingerprinting of Griffonia simplicifolia Baill .. Molecules 2019 Mar: 24. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472197/, accessed on July 1, 2019.

Winchester Hospital (2019): 5-Hydroxytryptophan. Health Library. https://www.winchesterhospital.org/health-library/article?id=21399, accessed on July 1, 2019.